These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11153446)

  • 1. Modeling interactions between adrenal suppression and T-helper lymphocyte trafficking during multiple dosing of methylprednisolone.
    Chow FS; Sharma A; Jusko WJ
    J Pharmacokinet Biopharm; 1999 Dec; 27(6):559-75. PubMed ID: 11153446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamic model for joint exogenous and endogenous corticosteroid suppression of lymphocyte trafficking.
    Milad MA; Ludwig EA; Anné S; Middleton E; Jusko WJ
    J Pharmacokinet Biopharm; 1994 Dec; 22(6):469-80. PubMed ID: 7473077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoimmunodynamics of methylprednisolone: trafficking of helper T lymphocytes.
    Fisher LE; Ludwig EA; Jusko WJ
    J Pharmacokinet Biopharm; 1992 Aug; 20(4):319-31. PubMed ID: 1479558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylprednisolone pharmacokinetics and pharmacodynamics in chronic renal failure.
    Jusko WJ; Milad MA; Ludwig EA; Lew KH; Kohli RK
    Clin Nephrol; 1995 Jan; 43 Suppl 1():S16-9. PubMed ID: 7781199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid dose sparing: pharmacodynamic responses to single versus divided doses of methylprednisolone in man.
    Reiss WG; Slaughter RL; Ludwig EA; Middleton E; Jusko WJ
    J Allergy Clin Immunol; 1990 Jun; 85(6):1058-66. PubMed ID: 2191992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 am versus 4 pm.
    Fisher LE; Ludwig EA; Wald JA; Sloan RR; Middleton E; Jusko WJ
    Clin Pharmacol Ther; 1992 Jun; 51(6):677-88. PubMed ID: 1535301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic effects of coadministration of methylprednisolone and tacrolimus in rabbits.
    Piekoszewski W; Chow FS; Jusko WJ
    J Pharmacol Exp Ther; 1994 Apr; 269(1):103-9. PubMed ID: 7513355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of methylprednisolone in obesity.
    Dunn TE; Ludwig EA; Slaughter RL; Camara DS; Jusko WJ
    Clin Pharmacol Ther; 1991 May; 49(5):536-49. PubMed ID: 1827621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunodynamics of methylprednisolone induced T-cell trafficking and deactivation using whole blood lymphocyte proliferation techniques in the rat.
    Fasanmade AA; Jusko WJ
    Biopharm Drug Dispos; 1999 Jul; 20(5):255-61. PubMed ID: 10594870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics.
    Lew KH; Ludwig EA; Milad MA; Donovan K; Middleton E; Ferry JJ; Jusko WJ
    Clin Pharmacol Ther; 1993 Oct; 54(4):402-14. PubMed ID: 8222483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraceptive effects on methylprednisolone pharmacokinetics and pharmacodynamics.
    Slayter KL; Ludwig EA; Lew KH; Middleton E; Ferry JJ; Jusko WJ
    Clin Pharmacol Ther; 1996 Mar; 59(3):312-21. PubMed ID: 8653994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic interactions between diltiazem and methylprednisolone in healthy volunteers.
    Booker BM; Magee MH; Blum RA; Lates CD; Jusko WJ
    Clin Pharmacol Ther; 2002 Oct; 72(4):370-82. PubMed ID: 12386639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenal gland function in dogs given methylprednisolone.
    Spencer KB; Thompson FN; Clekis T; Lorenz MD
    Am J Vet Res; 1980 Sep; 41(9):1503-6. PubMed ID: 6255839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered methylprednisolone pharmacodynamics in healthy subjects with histamine N-methyltransferase C314T genetic polymorphism.
    Hon YY; Jusko WJ; Spratlin VE; Jann MW
    J Clin Pharmacol; 2006 Apr; 46(4):408-17. PubMed ID: 16554448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects.
    Kong AN; Ludwig EA; Slaughter RL; DiStefano PM; DeMasi J; Middleton E; Jusko WJ
    Clin Pharmacol Ther; 1989 Dec; 46(6):616-28. PubMed ID: 2689044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immediate suppression of endogenous cortisol secretion after single oral administration of 6-alpha-methylprednisolone].
    Hampe S; Haen E; Emslander HP
    Wien Med Wochenschr; 1995; 145(17-18):501-2. PubMed ID: 8588385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the pituitary-adrenal axis function following single intraarticular injection of methylprednisolone.
    Mader R; Lavi I; Luboshitzky R
    Arthritis Rheum; 2005 Mar; 52(3):924-8. PubMed ID: 15751089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortisol pharmacodynamics after methylprednisolone administration in young and elderly males.
    Tornatore KM; Logue G; Venuto RC; Davis PJ
    J Clin Pharmacol; 1997 Apr; 37(4):304-11. PubMed ID: 9115056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+ and CD8+ lymphocyte and cortisol response patterns in elderly and young males after methylprednisolone exposure.
    Tornatore KM; Venuto RC; Logue G; Davis PJ
    J Med; 1998; 29(3-4):159-83. PubMed ID: 9865456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pharmacokinetic/pharmacodynamic approach to predict the cumulative cortisol suppression of inhaled corticosteroids.
    Meibohm B; Hochhaus G; Möllmann H; Barth J; Wagner M; Krieg M; Stöckmann R; Derendorf H
    J Pharmacokinet Biopharm; 1999 Apr; 27(2):127-47. PubMed ID: 10567952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.